Teresa DeLuca - Aug 4, 2021 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: Director
Signature: /s/ Teresa DeLuca
Stock symbol: ATNF
Transactions as of: Aug 4, 2021
Transactions value $: $0
Form type: 4
Date filed: 8/5/2021, 05:18 PM
Previous filing: Jul 13, 2021
Next filing: Aug 12, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ATNF	Common Stock						0	Aug 4, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATNF	Non-Qualified Stock Option (right to buy)	Award	$0	+79K		$0.00	79K	Aug 4, 2021	Common Stock	79K	$7.56	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated under the Exchange Act.
F2	The Options vest at the rate of 1/48th of such options ratably on a monthly basis over the following 48 months following the grant date, on the last day of each calendar month (beginning on August 31, 2021), subject to the holder's continued service to the Company.